Consequently, in 2024, the EU’s trade surplus in medicinal and pharmaceutical products came to a total of €193.6 billion, marking a record high.

Top extra-EU exporters: Germany, Ireland and Belgium

In 2024, Germany was the EU’s largest extra-EU exporter of medicinal and pharmaceutical products (€67.9 billion), followed by Ireland (€56.6 billion) and Belgium (€41.4 billion).

The largest extra-EU importers were Germany (€23.0 billion), Belgium (€21.3 billion) and the Netherlands (€14.7 billion).

Main trade partners: US and Switzerland

The main destination for extra-EU exports of medicinal and pharmaceutical products in 2024 was the United States (38.2% of all exports outside the EU; €119.8 billion), followed by Switzerland (16.4%; €51.3 billion) and the United Kingdom (5.8%; €18.2 billion).

Most of the imports to the EU came from the United States (38.3%; €45.9 billion), Switzerland (32.6%; €39.1 billion) and the United Kingdom (7.3%; €8.7 billion).

Source: Eurostat
Legal Notice: The information in this article is intended for information purposes only. It is not intended for professional information purposes specific to a person or an institution. Every institution has different requirements because of its own circumstances even though they bear a resemblance to each other. Consequently, it is your interest to consult on an expert before taking a decision based on information stated in this article and putting into practice. Neither Karen Audit nor related person or institutions are not responsible for any damages or losses that might occur in consequence of the use of the information in this article by private or formal, real or legal person and institutions.